Log in to save to my catalogue

Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimenta...

Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimenta...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3542611

Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models

About this item

Full title

Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models

Publisher

London: Nature Publishing Group UK

Journal title

Cell death & disease, 2012-11, Vol.3 (11), p.e437-e437

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Necrostatin-1 (Nec-1) is widely used in disease models to examine the contribution of receptor-interacting protein kinase (RIPK) 1 in cell death and inflammation. We studied three Nec-1 analogs: Nec-1, the active inhibitor of RIPK1, Nec-1 inactive (Nec-1i), its inactive variant, and Nec-1 stable (Nec-1s), its more stable variant. We report that Nec...

Alternative Titles

Full title

Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3542611

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3542611

Other Identifiers

ISSN

2041-4889

E-ISSN

2041-4889

DOI

10.1038/cddis.2012.176

How to access this item